
$1.70M in average volume shows that Trevi Therapeutics Inc (TRVI) is heading in the right direction
On Monday, Trevi Therapeutics Inc (NASDAQ: TRVI) was 7.02% up from the session before settling in for the closing price of $6.55. A 52-week range
On Monday, Trevi Therapeutics Inc (NASDAQ: TRVI) was 7.02% up from the session before settling in for the closing price of $6.55. A 52-week range
Trevi Therapeutics Inc (NASDAQ: TRVI) kicked off on Tuesday, down -1.60% from the previous trading day, before settling in for the closing price of $5.95.
On Thursday, Trevi Therapeutics Inc (NASDAQ: TRVI) opened lower -0.50% from the last session, before settling in for the closing price of $5.98. Price fluctuations
On Tuesday, Trevi Therapeutics Inc (NASDAQ: TRVI) opened higher 4.20% from the last session, before settling in for the closing price of $5.47. Price fluctuations
On Monday, Trevi Therapeutics Inc (NASDAQ: TRVI) was -3.52%% drop from the session before settling in for the closing price of $5.96. A 52-week range
A new trading day began on Monday, with Trevi Therapeutics Inc (NASDAQ: TRVI) stock price up 4.02% from the previous day of trading, before settling
As on Thursday, Trevi Therapeutics Inc (NASDAQ: TRVI) got off with the flyer as it spiked 2.43% to $6.74, before settling in for the price
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.